Vireo Growth (FRA:K95) Cyclically Adjusted Revenue per Share: €13.80 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:K95 Vireo Growth Inc FRA:K95
55 GF Score
Price €8.64
GF Value €8.20
! 8 Warning Signs
View Full Analysis

What is Vireo Growth Cyclically Adjusted Revenue per Share?

Vireo Growth FRA:K95 +1.17% 55 Cyclically Adjusted Revenue per Share is €13.80 as of Mar. 2026. GuruFocus rates FRA:K95 with a GF Score™ of 55/100 and a GF Value™ of €8.20. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vireo Growth's adjusted revenue per share for the three months ended in Mar. 2026 was €2.551. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €13.80 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vireo Growth's average Cyclically Adjusted Revenue Growth Rate was -2.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vireo Growth was 3.50% per year. The lowest was -5.50% per year. And the median was 0.85% per year.

As of today (2026-08-09), Vireo Growth's current stock price is €8.64. Vireo Growth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €13.80. Vireo Growth's Cyclically Adjusted PS Ratio of today is 0.63.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vireo Growth was 12.35. The lowest was 0.17. And the median was 0.89.


Vireo Growth  (FRA:K95) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vireo Growth's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8.64/13.80
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vireo Growth was 12.35. The lowest was 0.17. And the median was 0.89.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vireo Growth Cyclically Adjusted Revenue per Share Related Terms


Vireo Growth Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Vireo Growth's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth Cyclically Adjusted Revenue per Share Chart

Vireo Growth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.46 16.69 15.11 16.01 13.38

Vireo Growth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.75 13.47 13.35 13.38 13.80

FRA:K95 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Cyclically Adjusted PS Ratio falls into.


FRA:K95
55GF Score
Vireo Growth Inc FRA:K95
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vireo Growth Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vireo Growth's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.551/330.2130*330.2130
=2.551

Current CPI (Mar. 2026) = 330.2130.

Vireo Growth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 2.567 254.202 3.335
201906 7.697 256.143 9.923
201909 7.999 256.759 10.287
201912 1.069 256.974 1.374
202003 3.717 258.115 4.755
202006 3.291 257.797 4.215
202009 2.824 260.280 3.583
202012 2.944 260.474 3.732
202103 2.863 264.877 3.569
202106 2.822 271.696 3.430
202109 2.698 274.310 3.248
202112 2.852 278.802 3.378
202203 3.326 287.504 3.820
202206 4.672 296.311 5.207
202209 4.459 296.808 4.961
202212 4.208 296.797 4.682
202303 4.174 301.836 4.566
202306 4.365 305.109 4.724
202309 4.908 307.789 5.266
202312 4.643 306.746 4.998
202403 4.645 312.332 4.911
202406 4.874 314.175 5.123
202409 3.378 315.301 3.538
202412 3.076 315.605 3.218
202503 1.853 319.799 1.913
202506 2.236 322.561 2.289
202509 2.466 324.800 2.507
202512 2.536 324.054 2.584
202603 2.551 330.213 2.551

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €13.80 mean?
Vireo Growth (FRA:K95) has a Cyclically Adjusted Revenue per Share of €13.80 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vireo Growth and its competitors.
Is Vireo Growth's Cyclically Adjusted Revenue per Share too high?
Vireo Growth's current Cyclically Adjusted Revenue per Share is €13.80. Overall, Vireo Growth has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Cyclically Adjusted Revenue per Share compare to ZTS?
Vireo Growth's Cyclically Adjusted Revenue per Share of €13.80 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vireo Growth and its competitors. Vireo Growth's current Cyclically Adjusted Revenue per Share is €13.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Vireo Growth (FRA:K95) has a current Cyclically Adjusted Revenue per Share of €13.80. The stock's GF Value™ is €8.20, compared to a current price of €8.64 — trading 5.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €13.80. Vireo Growth's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Vireo Growth (FRA:K95), the current Cyclically Adjusted Revenue per Share is €13.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (FRA:K95) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of €8.64 is trading 5.4% above its estimated GF Value™ of €8.20.

Key valuation signals for FRA:K95:

  • Cyclically Adjusted Revenue per Share: €13.80
  • GF Value™: €8.20 vs. price of €8.64 (5.4% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the FRA:K95 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vireo Growth Business Description

Other Exchanges VREOD:USAVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
55GF Score

Get the complete analysis for FRA:K95

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.64
Price
€8.20
GF Value